Default: npj Breast Cancer

ISSN:

Journal Home

Journal Guideline

npj Breast Cancer Q1 Unclaimed

Nature Publishing Group United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

npj Breast Cancer is a journal indexed in SJR in Oncology and Radiology, Nuclear Medicine and Imaging with an H index of 46. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 2790 €. The scope of the journal is focused on biophysics of cancer, metastasis, histopathology, secondary neoplasm occurrence, carcinogenesis, tumour microenvironment. It has an SJR impact factor of 2,275 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,275.

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Price

2790 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

npj Breast Cancer

2,275

SJR Impact factor

46

H Index

95

Total Docs (Last Year)

346

Total Docs (3 years)

4112

Total Refs

2003

Total Cites (3 years)

339

Citable Docs (3 years)

5.65

Cites/Doc (2 years)

43.28

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


Biophysics of cancer Metastasis Histopathology Secondary neoplasm occurrence Carcinogenesis Tumour microenvironment



Best articles by citations

Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy

Carly Bess Williams Elizabeth S Yeh Adam C Soloff
235 Citations View more

Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set

Hui Li Yitan Zhu Elizabeth S Burnside
150 Citations View more

MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer

Stephen Johnston Miguel Martin Angelo Di Leo
118 Citations View more

Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study

Valentina I Petkov Dave P Miller Nadia Howlader
89 Citations View more

The WISDOM Study: breaking the deadlock in the breast cancer screening debate

Laura J. Esserman
82 Citations View more

Inflammatory breast cancer: a model for investigating cluster-based dissemination

Mohit Kumar Jolly Marcelo Boareto Bisrat G. Debeb
75 Citations View more

Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants

Fresia Pareja Felipe C Geyer Caterina Marchiò
73 Citations View more

Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration

Samuel C Y Leung Torsten O Nielsen
73 Citations View more

Integrated radiomic framework for breast cancer and tumor biology using advanced machine learning and multiparametric MRI

Vishwa S. Parekh Michael A. Jacobs
69 Citations View more

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk

Thomas P. Slavin Kara N. Maxwell Jenna Lilyquist
66 Citations View more

Cell state plasticity, stem cells, EMT, and the generation of intra-tumoral heterogeneity

Geoffrey M. Wahl Benjamin T. Spike
65 Citations View more

The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening

Nehmat Houssami Kylie Hunter
62 Citations View more
SHOW MORE ARTICLES

Image analysis with deep learning to predict breast cancer grade, ER status, histologic subtype, and intrinsic subtype

Heather D. Couture Lindsay A. Williams Joseph Geradts
61 Citations View more

If we build it they will come: targeting the immune response to breast cancer

Margaret E. Gatti-Mays Justin M. Balko Sofia R. Gameiro
48 Citations View more

PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance)

Minetta C Liu Brandelyn N Pitcher Elaine R Mardis
47 Citations View more

Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy

Yu-Hsiang Chen Bradley A. Hancock Jeffrey P. Solzak
45 Citations View more

Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design

Jennifer A. Ligibel William T. Barry Catherine Alfano
41 Citations View more

21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer

Charles E. Geyer Gong Tang Eleftherios P. Mamounas
41 Citations View more

DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial

Denise M. Wolf Christina Yau Ashish Sanil
38 Citations View more

Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancer

Daniel G. Stover Carlos R. Gil Del Alcazar Jane Brock
38 Citations View more

Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry

Salomon M. Stemmer Mariana Steiner Shulamith Rizel
38 Citations View more

Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis

Shih-ying Huang Benjamin L. Franc Roy J. Harnish
37 Citations View more

Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer

Charlotte Vaysse Jon Lømo Øystein Garred
37 Citations View more

Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry

Salomon M. Stemmer Mariana Steiner Shulamith Rizel
36 Citations View more

FAQS